Rankings
▼
Calendar
IONS Q3 2018 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$12B
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$145M
+22.9% YoY
Gross Profit
$145M
100.0% margin
Operating Income
-$19M
-12.8% margin
Net Income
-$5M
-3.1% margin
EPS (Diluted)
$-0.03
QoQ Revenue Growth
+23.5%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$31M
Stock-Based Comp.
$35M
Balance Sheet
Total Assets
$2.2B
Total Liabilities
$1.4B
Stockholders' Equity
$711M
Cash & Equivalents
$480M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$145M
$118M
+22.9%
Gross Profit
$145M
$38M
+281.6%
Operating Income
-$19M
$11M
-264.2%
Net Income
-$5M
-$3M
-74.6%
Revenue Segments
Commercial
$83M
36%
SPINRAZA Royalties
$70M
31%
Research and Development Revenue Under Collaborative Agreements
$63M
27%
Licensing and Other Royalties
$13M
6%
← FY 2018
All Quarters
Q4 2018 →